Captain T Cell has successfully completed a major financing round, securing a total of EUR 20 million to advance its next-generation TCR-T therapies. The round was led by several new investors, with existing backers also increasing their commitments.…
Researchers and end users jointly develop forward-looking health technologies with funding of €4 million
- Combined capital will support the ongoing Phase 2a clinical trial of procizumab in cardiogenic shock
- Series C round was supported by both existing and new investors
Although menopause – also known as perimenopause – can significantly impair women's well-being and performance, medical education and support have often been inadequate to date. As part of the joint project “PETRA: AI-supported, educational therapy…
Professor Alexander Meyer will head the institute and in this role also holds the newly created professorship for Artificial Intelligence in Medicine.
Highly Cited Researchers 2025 list published
– Comprehensive TK-6302 data demonstrate preclinical efficacy and safety, supporting clinical readiness, alongside established scalable manufacturing
– TK-6302 Clinical Trial Application planned in Q4 2025 for initiation of the Phase 1 ATLAS trial…
Researchers from the Institute of Neurophysiology at Charité – Universitätsmedizin Berlin have uncovered new insights into how a key protein called CLIC1 regulates the movement of immune cells in the brain and shapes their response to danger signals.…
A collaboration led by Max Delbrück Center and University of Bath has uncovered how ancient viral DNA controls a gene linked to placenta development and pre-eclampsia, a life-threatening pregnancy disorder. The research, published in “Genome…
Contrary to common assumptions, a new study from the German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE) and Charité – Universitätsmedizin Berlin, shows that intermittent fasting (time-restricted eating) with an unchanged calorie intake…
